Hanks Richard 4

4 · CLARIVATE Plc · Filed Jun 15, 2021

Form 4

Period: 2021-06-14

Chief Financial Officer

Transactions

Exercise/Conversion
Ordinary Shares
2021-06-14$6.61/sh+73,997$489,120→ 140,880 total
Exercise/Conversion
Ordinary Shares
2021-06-14$10.39/sh+52,854$549,153→ 193,734 total
Exercise/Conversion
Ordinary Shares
2021-06-14$14.18/sh+52,854$749,470→ 246,588 total
Exercise/Conversion
Ordinary Shares
2021-06-14$17.96/sh+31,712$569,548→ 278,300 total
Exercise/Conversion
Ordinary Shares
2021-06-14$6.61/sh+4,757$31,444→ 283,057 total
Tax Payment
Ordinary Shares
2021-06-14$26.00/sh−91,877$2,388,802→ 191,180 total
Sale
Ordinary Shares
2021-06-14$26.00/sh−124,297$3,231,722→ 66,883 total
Exercise/Conversion
Stock Options
2021-06-14−73,997→ 73,997 total
Exercise: $6.61Exp: 2027-03-02→ Ordinary Shares (73,997 underlying)
Exercise/Conversion
Stock Options
2021-06-14−52,854→ 52,854 total
Exercise: $10.39Exp: 2027-03-02→ Ordinary Shares (52,854 underlying)
Exercise/Conversion
Stock Options
2021-06-14−52,854→ 52,854 total
Exercise: $14.18Exp: 2027-03-02→ Ordinary Shares (52,854 underlying)
Exercise/Conversion
Stock Options
2021-06-14−31,712→ 31,713 total
Exercise: $17.96Exp: 2027-03-02→ Ordinary Shares (31,712 underlying)
Exercise/Conversion
Stock Options
2021-06-14−4,757→ 4,756 total
Exercise: $6.61Exp: 2027-05-22→ Ordinary Shares (4,757 underlying)

Footnotes (3)

[F1]Represents shares withheld for payment of exercise price.
[F2]Represents the remaining un-exercised portion of a March 3, 2017 grant of stock options; the reported stock options became exercisable on November 30, 2020.
[F3]Represents the remaining unexercised portion of a May 23, 2017 grant of stock options; 50% of the reported stock options became exercisable on each of October 3, 2020 and November 30, 2020.

Documents

1 file